Niawanlou Dara
Overview
Explore the profile of Niawanlou Dara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beshir K, Diallo N, Some F, Sombie S, Zongo I, Fofana B, et al.
Antimicrob Agents Chemother
. 2021 Jun;
65(8):e0087321.
PMID: 34060901
A recent randomized controlled trial, the WANECAM (West African Network for Clinical Trials of Antimalarial Drugs) trial, conducted at seven centers in West Africa, found that artemether-lumefantrine, artesunate-amodiaquine, pyronaridine-artesunate, and...
2.
Talman A, Ouologuem D, Love K, Howick V, Mulamba C, Haidara A, et al.
Front Microbiol
. 2020 Mar;
11:246.
PMID: 32194521
remains one of the leading causes of child mortality, and nearly half of the world's population is at risk of contracting malaria. While pathogenesis results from replication of asexual forms...
3.
Dama S, Niangaly H, Ouattara A, Sagara I, Sissoko S, Traore O, et al.
Malar J
. 2017 Feb;
16(1):59.
PMID: 28148267
Background: Artemisinin-based combination therapy is the recommended first-line treatment for uncomplicated falciparum malaria worldwide. However, recent studies conducted in Mali showed an increased frequency of recurrent parasitaemia following artemether-lumefantrine (AL)...
4.
Sagara I, Beavogui A, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, et al.
Lancet Infect Dis
. 2015 Nov;
16(2):189-98.
PMID: 26601738
Background: Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-artesunate after treatment of the first...
5.
Dicko A, Barry A, Dicko M, Diallo A, Tembine I, Dicko Y, et al.
PLoS One
. 2011 Aug;
6(8):e23390.
PMID: 21858096
Background: Intermittent preventive treatment of malaria in children (IPTc) is a promising strategy for malaria control. A study conducted in Mali in 2008 showed that administration of three courses of...
6.
Dicko A, Diallo A, Tembine I, Dicko Y, Dara N, Sidibe Y, et al.
PLoS Med
. 2011 Feb;
8(2):e1000407.
PMID: 21304923
Background: Previous studies have shown that in areas of seasonal malaria transmission, intermittent preventive treatment of malaria in children (IPTc), targeting the transmission season, reduces the incidence of clinical malaria....
7.
Ndiaye J, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, et al.
Malar J
. 2009 Jun;
8:125.
PMID: 19505304
Background: The use of artemisinin derivative-based combination therapy (ACT) such as artesunate plus amodiaquine is currently recommended for the treatment of uncomplicated Plasmodium falciparum malaria. Fixed-dose combinations are more adapted...
8.
Sagara I, Rulisa S, Mbacham W, Adam I, Sissoko K, Maiga H, et al.
Malar J
. 2009 Apr;
8:63.
PMID: 19366448
Background: The efficacy of artemisinin-based combination therapy has already been demonstrated in a number of studies all over the world, and some of them can be regarded as comparably effective....